iANTHUS CAPITAL HOLDINGS (ITHUF) Amortization of Deferred Charges (2020 - 2023)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Amortization of Deferred Charges came in at -$7.6 million in Q3 2023, down 153.24% year-on-year from $14.3 million in Q3 2022, and down 200.0% quarter-over-quarter from $7.6 million in Q2 2023.
iANTHUS CAPITAL HOLDINGS (ITHUF) Amortization of Deferred Charges (2020 - 2023) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting -$7.6 million for Q3 2023.
- Amortization of Deferred Charges for Q3 2023 came in at -$7.6 million, down 153.24% year-over-year; the trailing twelve-month figure through Sep 2023 was -$14.3 million (down 1957.1% YoY), and the FY2022 annual result was $804000.0, down 52.06% from the prior year.
- Amortization of Deferred Charges came in at -$7.6 million for Q3 2023 at iANTHUS CAPITAL HOLDINGS, down from $7.6 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $14.3 million in Q3 2022 to a low of -$15.8 million in Q4 2021.
- The 4-year median for Amortization of Deferred Charges is $5.1 million (2020), against an average of $1.2 million.
- Across the five-year window, Amortization of Deferred Charges tumbled 1078.5% in 2021 and surged 249.98% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Amortization of Deferred Charges stood at -$1.3 million in 2020, then sank by 1078.5% to -$15.8 million in 2021, then grew by 9.48% to -$14.3 million in 2022, then jumped by 46.76% to -$7.6 million in 2023.
- The last three Amortization of Deferred Charges figures came in at -$7.6 million (Q3 2023), $7.6 million (Q2 2023), and -$14.3 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -7.63 Mn |
| Sep 30, 2023 | -7.63 Mn |
| Jun 30, 2023 | 7.63 Mn |
| Jun 30, 2023 | 7.63 Mn |
| Dec 31, 2022 | -14.34 Mn |
| Dec 31, 2022 | -14.34 Mn |
| Sep 30, 2022 | 14.34 Mn |
| Sep 30, 2022 | 14.34 Mn |
| Jun 30, 2022 | -5.09 Mn |
| Jun 30, 2022 | -5.09 Mn |
| Mar 31, 2022 | 5.89 Mn |
| Mar 31, 2022 | 5.89 Mn |
| Dec 31, 2021 | -15.84 Mn |
| Dec 31, 2021 | -15.84 Mn |
| Sep 30, 2021 | 5.96 Mn |
| Sep 30, 2021 | 5.96 Mn |
| Jun 30, 2021 | 5.88 Mn |
| Jun 30, 2021 | 5.88 Mn |
| Mar 31, 2021 | 5.68 Mn |
| Mar 31, 2021 | 5.68 Mn |